Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 1996
Business Overview: Global manufacturer of oral, personal, and household care products and pet nutrition (Hill's Pet Nutrition).
Key Financial Metrics
| Metric ($ Millions) | Q3 1996 | Q3 1995 | 9 Months 1996 | 9 Months 1995 |
|---|---|---|---|---|
| Net Sales | 2,230.6 | 2,134.4 | 6,451.6 | 6,205.4 |
| Gross Profit | 1,094.8 | 1,024.7 | 3,159.1 | 2,974.6 |
| Gross Margin % | 49.1% | 48.0% | 49.0% | 47.9% |
| Net Income | 160.9 | (250.2) | 453.3 | 49.5 |
| Diluted EPS | $0.99 | $(1.76) | $2.79 | $0.23 |
| Operating Cash Flow (9mo) | $580.7 (vs $513.8 prior year) | |||
| Working Capital | $570.6 (as of Sept 30, 1996) | |||
| Total Debt (Current + Long-term) | $3,276.5 (as of Sept 30, 1996) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 1996 sales increased 5% year-over-year, driven by 6% volume growth. Nine-month sales rose 4% on 5% volume growth.
- Profitability Surge: Net income for Q3 1996 was $160.9 million, a significant improvement over the $250.2 million loss in Q3 1995. The prior year loss was heavily impacted by a one-time restructuring charge of $460.5 million.
- Margin Expansion: Gross profit margin improved to 49.1% in Q3 1996 from 48.0% in Q3 1995, attributed to cost reductions, product mix changes, and restructuring benefits.
- EBIT Growth: Earnings Before Interest and Taxes (EBIT) increased 23.8% in Q3 and 7.2% for the nine-month period compared to the prior year (excluding the 1995 restructuring charge).
- Regional Performance: Latin America sales grew 9% in Q3; Hill's Pet Nutrition sales increased 11% in Q3. Europe sales were flat due to a strengthening U.S. Dollar.
Outlook, Risks, and Management Commentary
- Restructuring Status: The 1995 restructuring program reserves stood at $310.5 million as of September 30, 1996. Management expects to finance remaining costs through operating cash flow with no significant liquidity impact.
- Regulatory Contingency (Brazil): The acquisition of the Kolynos oral care business in Brazil was approved by the Administrative Council of Economic Defense (CADE) subject to conditions regarding the toothpaste market. The company must choose between suspending the Kolynos trademark for four years, licensing it exclusively to a third party for 20+ years, or selling the trademark. The company is currently developing proposals to address these conditions.
- Liquidity: Commercial paper outstanding was $968.2 million, classified as long-term debt due to the intent to refinance. Net cash provided by operations increased to $580.7 million for the first nine months of 1996.
- Dividends: Dividends declared per common share were $1.41 for the nine months ended September 30, 1996, compared to $1.29 in the prior year.
Investor Verification Checklist
- Restructuring Charge Impact: Verify the comparability of 1995 results by excluding the $460.5 million one-time charge recorded in Q3 1995.
- Brazilian Regulatory Resolution: Monitor the company's final decision regarding the CADE conditions for the Kolynos trademark in Brazil and potential financial implications of divestiture or licensing.
- Currency Effects: Assess the impact of the strengthening U.S. Dollar on reported sales in Europe and other international regions versus underlying volume growth.
- Debt Classification: Review the $968.2 million commercial paper classified as long-term debt to ensure refinancing capabilities remain intact.
- Volume vs. Price: Confirm that sales growth is primarily driven by volume (reported as 5-6%) rather than price increases, as indicated in management commentary.